Figure 3
Changes in the mean arterial pressure (MAP) and percutaneous arterial oxygen saturation (SpO2). (a) indicates the MAP values: 91.5 (86.8–97.5) mmHg just before sedation and 89 (74.5–91) mmHg just before the start of treatment after midazolam administration (P = 0.024) in the dementia-negative group; 83 (78.5–99.3) mmHg just before sedation and 84 (74.5–99.5) mmHg just before the start of treatment after midazolam administration in the dementia-positive group. (b) indicates the SpO2 values: 97% (96–97) just before sedation and 96.5% (93.8–97.3) just before the start of treatment after midazolam administration in the dementia-negative group; 96.5% (96–98) just before sedation and 92% (90.5–97.5) just before the start of treatment after midazolam administration (P = 0.046) in the dementia-positive group.
